ARTICLE | Clinical News
Spectrum Pharmaceuticals preclinical data
April 25, 2005 7:00 AM UTC
In a rat model of breast cancer, SPI-1620 followed by paclitaxel significantly reduced the tumor volume compared to paclitaxel alone. The endothelin B agonist led to complete remission in 15% of rats ...